Holen Sie sich die Stockscreener-App
1.93
3.98%
-0.08
Handel nachbörslich:
1.96
0.03
+1.55%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.01
Offen:
$1.97
24-Stunden-Volumen:
748.02K
Relative Volume:
0.51
Marktkapitalisierung:
$320.38M
Einnahmen:
$137.74M
Nettoeinkommen (Verlust:
$-27.97M
KGV:
-12.06
EPS:
-0.16
Netto-Cashflow:
$-9.61M
1W Leistung:
-8.10%
1M Leistung:
+4.89%
6M Leistung:
+20.62%
1J Leistung:
-46.91%
1-Tages-Spanne:
$1.92
$2.00
1-Wochen-Bereich:
$1.92
$2.209
52-Wochen-Spanne:
$1.04
$3.73
Heron Therapeutics Inc Stock (HRTX) Company Profile
Firmenname
Heron Therapeutics Inc
Sektor
Branche
Telefon
(858) 251-4400
Adresse
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Vergleichen Sie HRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.93 | 320.38M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-23 | Eingeleitet | CapitalOne | Overweight |
| 2024-03-13 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Buy |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-04-05 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2018-03-01 | Bestätigt | Needham | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Outperform |
| 2017-09-27 | Eingeleitet | Northland Capital | Outperform |
| 2017-02-27 | Eingeleitet | Needham | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-09-06 | Fortgesetzt | Lake Street | Buy |
| 2016-05-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-10 | Eingeleitet | Lake Street | Buy |
| 2015-09-23 | Bestätigt | Leerink Partners | Outperform |
| 2015-09-02 | Eingeleitet | BofA/Merrill | Buy |
| 2015-08-03 | Bestätigt | Brean Capital | Buy |
| 2015-06-30 | Bestätigt | JMP Securities | Mkt Outperform |
| 2015-06-19 | Bestätigt | Leerink Partners | Outperform |
| 2014-08-07 | Eingeleitet | Noble Financial | Buy |
Alle ansehen
Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - MarketBeat
What is HC Wainwright's Forecast for HRTX Q2 Earnings? - MarketBeat
Jane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Q2 Earnings Forecast for HRTX Issued By HC Wainwright - Defense World
Heron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC Wainwright - Defense World
Heron Therapeutics (HRTX) Receives "Buy" Initiation from HC Wainwright | HRTX Stock News - GuruFocus
HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target - marketscreener.com
Heron Therapeutics (HRTX) Gains Buy Rating and Positive Outlook | HRTX Stock News - GuruFocus
Heron Therapeutics (NASDAQ:HRTX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Nuveen Asset Management LLC Sells 792,421 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to “Buy” - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lessened by Two Sigma Investments LP - MarketBeat
Nuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Raised by Bank of America Corp DE - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by ProShare Advisors LLC - Defense World
Two Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - ACCESS Newswire
Northern Trust Corp Buys 21,769 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street Zen - MarketBeat
3,075,809 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Point72 Asset Management L.P. - MarketBeat
20,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Purchased by Focus Partners Wealth - Defense World
Tang Capital Management LLC Purchases 290,271 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Stonepine Capital Management LLC Buys Shares of 700,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
D. E. Shaw & Co. Inc. Trims Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Q&A with Barry Quart, CEO at Connect Biopharma - citybiz
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World
Raymond James Financial Inc. Buys New Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Bridgeway Capital Management LLC Acquires Shares of 300,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Volatility Of Heron Therapeutics Inc (HRTX) Reaches 9.24%: Make Sure To Keep Your Seat Tight! - Stocksregister
J. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What is Northland Capmk's Estimate for HRTX Q2 Earnings? - MarketBeat
Clearline Capital LP Has $2.77 Million Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Buys Shares of 135,722 Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wells Fargo & Company MN Has $114,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX) - MarketBeat
Barclays PLC Grows Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):